Twist Bioscience Corp (TWST)
38.96
-3.53
(-8.31%)
USD |
NASDAQ |
Nov 14, 16:00
38.90
-0.06
(-0.15%)
After-Hours: 07:41
Twist Bioscience Research and Development Expense (Quarterly): 22.47M for June 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 22.47M |
| March 31, 2024 | 24.15M |
| December 31, 2023 | 23.10M |
| September 30, 2023 | 23.75M |
| June 30, 2023 | 24.53M |
| March 31, 2023 | 27.38M |
| December 31, 2022 | 31.24M |
| September 30, 2022 | 29.61M |
| June 30, 2022 | 36.84M |
| March 31, 2022 | 31.23M |
| December 31, 2021 | 22.63M |
| September 30, 2021 | 19.44M |
| June 30, 2021 | 19.84M |
| March 31, 2021 | 15.79M |
| Date | Value |
|---|---|
| December 31, 2020 | 14.00M |
| September 30, 2020 | 11.64M |
| June 30, 2020 | 10.44M |
| March 31, 2020 | 10.63M |
| December 31, 2019 | 10.30M |
| September 30, 2019 | 10.50M |
| June 30, 2019 | 9.007M |
| March 31, 2019 | 8.907M |
| December 31, 2018 | 7.273M |
| September 30, 2018 | 6.065M |
| June 30, 2018 | 5.268M |
| March 31, 2018 | 4.711M |
| December 31, 2017 | 4.303M |
| September 30, 2017 | 4.851M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
10.30M
Minimum
Dec 2019
36.84M
Maximum
Jun 2022
21.53M
Average
22.63M
Median
Dec 2021
Research and Development Expense (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 9.275M |
| Retractable Technologies Inc | 0.1991M |
| InfuSystems Holdings Inc | -- |
| Xtant Medical Holdings Inc | 0.636M |
| Catheter Precision Inc | 0.081M |